 |
Hikma acquires rights to portfolio of Takeda brands for MenaHikma Pharmaceuticals, a multinational pharmaceutical group, has agreed with Takeda Pharmaceuticals International to acquire the rights to 17 brands currently licensed to Hikma for select territories in the Mena region. More… |
 |
Takeda named Top Employer in Mideast againTakeda, a global biopharmaceutical leader headquartered in Japan, has been named a Top Employer in 2021 in the Middle East for the second consecutive year by Top Employers Institute. This is also the fourth year in a row Takeda has received th More… |
 |
Takeda partners with global plasma firms in big Covid fightTakeda, one of the world's leading global biopharmaceutical companies, has joined forces with some of the world's leading plasma companies to focus on developing a hyperimmune globulin in the worldwide fight against Covid-19 pandemic. More… |
|
Takeda partners with global plasma firms in big Covid fightTakeda, one of the world's leading global biopharmaceutical companies, has joined forces with some of the world's leading plasma companies to focus on developing a hyperimmune globulin in the worldwide fight against Covid-19 pandemic. More… |
 |
Summertown Interiors delivers Takeda's new Dubai HQUAE-based Summertown Interiors, a leading fit-out contractor specialising in green interiors, said it has successfully delivered a stunning design and build project for the new Middle East headquarters for Japanese pharmaceutical company, Take More… |
 |
Takeda named top employer in the UAE, Saudi Arabia and EgyptTakeda Pharmaceutical Company Limited, (Takeda) has announced it has become part of a select group to receive global Top Employer. In ICMEA, the Top Employer certification went for the third time running to Takeda entities in Turkey, Ukraine, More… |
|
Takeda named top employer in the UAE, Saudi Arabia and EgyptTakeda Pharmaceutical Company Limited, (Takeda) has announced it has become part of a select group to receive global Top Employer. In ICMEA, the Top Employer certification went for the third time running to Takeda entities in Turkey, Ukraine, More… |
 |
Takeda completes sale of $200m pharma assets to AcinoTakeda Pharmaceutical Company Limited today completed its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Gr More… |
|
Takeda completes sale of $200m pharma assets to AcinoTakeda Pharmaceutical Company Limited today completed its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Gr More… |
 |
Takeda appoints new area headTakeda Pharmaceutical Company Limited announced today the appointment of Dr Mahender Nayak as area head for the company’s ICMEA (India, CIS, Middle East, Turkey, and Africa) Area. In the capacity, D More… |
